Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

High Tech and High Touch (HT2): Transforming Patient Engagement Through Portal Technology at the Bedside

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02943109
Recruitment Status : Completed
First Posted : October 24, 2016
Last Update Posted : May 15, 2020
Sponsor:
Information provided by (Responsible Party):
Ann McAlearney, Ohio State University

Brief Summary:
A large-scale randomized control trial (RCT) of the impact and use of an inpatient tablet-based patient portal embedded in a larger mixed methods study to examine changes in patient experiences and outcomes, and subsequent ambulatory patient portal usage.

Condition or disease Intervention/treatment Phase
Physician-Patient Relations Inpatient Facility Diagnoses Electronic Health Records Outpatient Other: High Touch Other: Low Touch Other: High Tech Other: Low Tech Not Applicable

Detailed Description:

The appropriate use of technology to actively engage with patients who suffer from multiple chronic conditions, called multimorbidity, is one of the frontiers of both research and practice. For multimorbid patients, engagement in disease management activities is particularly critical, and evidence shows that enhanced patient self-management can lead to better control of chronic illness. One tool finding increasing use is the patient portal, and its pervasiveness is supported by virtue of its role as a component of the Meaningful Use criteria. A patient portal is a tethered personal health record (tPHR) that links to the patient's electronic health record, facilitating communication and engagement activities with healthcare providers. While most tPHRs have been focused on outpatient activities, a new class of tools focused on the inpatient experience has begun deployment in 2014.

In response, this study supports the conduct of the first, large-scale randomized control trial (RCT) of the impact and use of an inpatient tablet-based patient portal embedded in a larger mixed methods study to examine changes in patient experiences and outcomes, and subsequent ambulatory patient portal usage. The investigators aim to study how access to a patient portal tailored to the inpatient stay can improve patient experience and increase patient engagement by improving patients' perception of the process of care while in the hospital (patient experience), increasing patients' self-efficacy for managing their chronic conditions (patient engagement), and facilitating use of a patient portal for care management activities after discharge (patient engagement).

The study site is a world-class healthcare facility with the ability to provide access to a patient portal designed specifically for the inpatient experience, bridging to outside the hospital after discharge.

Currently, this inpatient technology exists in only one other hospital in the US, but the investigators expect that as inpatient PHRs become more readily available, the need for clarity on this issue will only increase. The investigator's evaluation is a mixed-methods design consisting of primary data collection through surveys and interviews throughout the study period, and secondary data collection from the electronic health record and health system metadata. This study will offer insight into a potentially important mechanism to facilitate patient self-management.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 3782 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Single (Participant)
Primary Purpose: Health Services Research
Official Title: High Tech and High Touch (HT2): Transforming Patient Engagement Through Portal Technology at the Bedside
Actual Study Start Date : December 2016
Actual Primary Completion Date : February 2020
Actual Study Completion Date : April 2020

Arm Intervention/treatment
Experimental: High tech, high touch
Patient receives the full version of MyChart Bedside. Patient receives training/intervention from technology navigator
Other: High Touch
Participants receives an in person visit from an "technology navigator" who helps to explain the technology to the patient.

Other: High Tech
Patient receives full-suite access to an inpatient patient portal with bi-directional communication enabled.

Experimental: Low tech, high touch
Patient receives the non-interactional version of MyChart Bedside. Patient receives training/intervention from technology navigator
Other: High Touch
Participants receives an in person visit from an "technology navigator" who helps to explain the technology to the patient.

Other: Low Tech
Patient receives a limited access version of the inpatient patient portal with bi-directional communication disabled.

Experimental: High tech, low touch
Patient receives the full version of MyChart Bedside. Patient receives online training, only
Other: Low Touch
Participants receives a visit from a "patient navigator" who helps to explain how to navigate the hospital system (active control).

Other: High Tech
Patient receives full-suite access to an inpatient patient portal with bi-directional communication enabled.

Experimental: Low tech, low touch
Patient receives the non-interactional version of MyChart Bedside. Patient receives online training, only
Other: Low Touch
Participants receives a visit from a "patient navigator" who helps to explain how to navigate the hospital system (active control).

Other: Low Tech
Patient receives a limited access version of the inpatient patient portal with bi-directional communication disabled.




Primary Outcome Measures :
  1. MyChart Bedside Use [ Time Frame: through study completion, an average of 1 year ]
    Frequency of inpatient portal use (based on log file analysis)

  2. Patient Satisfaction and Involvement with Care [ Time Frame: through study completion, an average of 1 year ]
    Survey responses on admission and post-discharge surveys; higher scores are better outcomes


Secondary Outcome Measures :
  1. MyChart adoption and use [ Time Frame: Up to 3 months post-discharge ]
    Use of outpatient portal (based on log file analysis)

  2. Self-Efficacy [ Time Frame: through study completion, an average of 1 year ]
    Survey responses on admission and post-discharge surveys; higher scores are better outcomes



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion criteria:

  • patient accepted MyChart Bedside tablet
  • patient available in their room
  • capable of providing informed consent

Exclusion criteria:

  • Patient in a pilot unit where Full Tech was available prior to study start
  • Patient was less than 18 years of age

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02943109


Locations
Layout table for location information
United States, Ohio
Ohio State University
Columbus, Ohio, United States, 43210
Sponsors and Collaborators
Ohio State University
Investigators
Layout table for investigator information
Principal Investigator: Ann S McAlearney, ScD Ohio State University
Publications:
Layout table for additonal information
Responsible Party: Ann McAlearney, Professor of Family Medicine and Executive Director, CATALYST, Ohio State University
ClinicalTrials.gov Identifier: NCT02943109    
Other Study ID Numbers: R01HS024091 ( U.S. AHRQ Grant/Contract )
First Posted: October 24, 2016    Key Record Dates
Last Update Posted: May 15, 2020
Last Verified: May 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Ann McAlearney, Ohio State University:
patient portal
Health Information Technology
Electronic Health Records
Inpatient Care
Outpatient Care
Patient Engagement